Cogent Biosciences Inc
(COGT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 41,320 | 0 |
| Marketable Securities | 27,180 | 0 |
| Receivables | 920 | 0 |
| Other current assets | 310 | 0 |
| TOTAL | $69,730 | $0 |
| Non-Current Assets | ||
| Other Non-Current Assets | 1,250 | 0 |
| TOTAL | $1,250 | $N/A |
| Total Assets | $75,550 | $0 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 1,450 | 0 |
| Accrued Expenses | 1,320 | 0 |
| Other current liabilities | 5,960 | 0 |
| TOTAL | $8,730 | $0 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 77,080 | 0 |
| TOTAL | $91,500 | $N/A |
| Total Liabilities | $100,240 | $0 |
| Shareholders' Equity | ||
| Common Shares | 10 | 0 |
| Retained earnings | -25,840 | 0 |
| Other shareholders' equity | -20 | 0 |
| TOTAL | $-24,690 | $0 |
| Total Liabilities And Equity | $75,550 | $0 |